"Executive Summary Glycogen Synthase Kinase 3 Beta (GSK-3β) Inhibitors Therapeutics Market : The global glycogen synthase kinase 3 beta (GSK-3β) inhibitors therapeutics market size was valued at USD 2.19 billion in 2024 and is projected to reach USD 3.29 billion by 2032, with a CAGR of 5.20% during the forecast period of 2025 to 2032. Glycogen Synthase Kinase 3 Beta...